Women over 40 navigate weight loss against shifting hormones, slower baseline metabolism, and (often) plateau-prone weight history. The best GLP-1 programs for this cohort consider those factors rather than treating GLP-1 in isolation.
Who this list is for
Women in perimenopause/midlife seeking GLP-1 programs aware of hormonal context.
Ranked programs
| Provider | All-in monthly | Semaglutide | Tirzepatide | Compounded vs brand | Insurance accepted? | Last verified | |
|---|---|---|---|---|---|---|---|
| $199/mo | From $179/mo | From $249/mo | Compounded | No | See pricing → | ||
| $79/mo + Rx | Brand cost varies | Brand cost varies | Both | Yes | See pricing → | ||
| $209/mo | From $189/mo | From $259/mo | Compounded | No | See pricing → | ||
| $209/mo | From $189/mo | From $259/mo | Compounded | No | See pricing → | ||
| $1649/mo + Rx | Brand only — varies | Brand only — varies | Brand-name | Yes | See pricing → | ||
| $99/mo + Rx | Brand pricing — varies with insurance | Brand pricing — varies with insurance | Both | Yes | See pricing → |
Why we ranked them this way
- GLP-1 medications work in women over 40, but loss often slows and plateaus more than in younger cohorts. Programs that handle plateau coaching and dose-escalation thoughtfully matter more here.
- Programs that consider hormone status (perimenopause, menopause) alongside GLP-1 prescribing are best when weight gain coincided with hormonal shifts.
- Brand-name access via insurance is worth checking — many large-employer plans now cover Wegovy/Zepbound for documented BMI and the workup is often more thorough at women’s-health-aware programs.
The picks in detail
TMates
Best for: Compounded GLP-1 with hands-on clinical touch.
Watchout: Confirm what the higher tiers include vs the entry tier.
Pricing: $199/mo all-in (medication included) — semaglutide from $179/mo, tirzepatide from $249/mo.
Mochi Health
Best for: Brand-name access where insurance can apply.
Watchout: Final cost depends heavily on insurance and pharmacy.
Pricing: $79/mo membership + medication — semaglutide brand cost varies, tirzepatide brand cost varies.
Embody
Best for: Personalized compounded blends and hands-on support.
Watchout: Custom blends warrant extra scrutiny on ingredient transparency.
Pricing: $209/mo all-in (medication included) — semaglutide from $189/mo, tirzepatide from $259/mo.
Winona
Best for: Women navigating GLP-1 alongside menopause or hormone care.
Watchout: Best fit if you also want hormone-related care; otherwise simpler GLP-1 programs may cost less.
Pricing: $209/mo all-in (medication included) — semaglutide from $189/mo, tirzepatide from $259/mo.
Calibrate
Best for: Coaching-heavy, behavior-change-first program.
Watchout: Higher overall cost — best when you'll use the coaching.
Pricing: $1649/mo membership + medication — semaglutide brand only — varies, tirzepatide brand only — varies.
WeightWatchers
Best for: Brand-name GLP-1 with behavioral program and insurance billing.
Watchout: Total cost depends on insurance — without coverage, brand-name medication is $500-$1,300/mo.
Pricing: $99/mo membership + medication — semaglutide brand pricing — varies with insurance, tirzepatide brand pricing — varies with insurance.
Frequently asked questions
Do GLP-1s work for women in perimenopause?
Yes. GLP-1 medications work in perimenopausal women, though average weight loss may be lower than in younger cohorts due to baseline metabolic changes. Pairing GLP-1 with strength training and protein-forward eating is especially important in this group.
Should I take GLP-1 alongside HRT?
Many clinicians prescribe GLP-1 alongside hormone replacement therapy. Programs designed for women’s health (Winona, Mochi) are best positioned to coordinate both.
Why do I lose weight more slowly than younger women on the same GLP-1?
Resting metabolic rate declines roughly 1–2% per decade in adulthood, and lean mass typically declines faster after 40. The same dose produces less absolute weight loss in older patients on average.
Related guides
RangeYourself is reader-supported. We may earn a commission when you click on certain links — at no extra cost to you. Editorial recommendations are made independently. Last reviewed May 7, 2026.